Article

What we're reading ... March 12, 2010

Each week the staff of CURE shares some of what they've been reading the past week with our readers. Please let us know what you think and what you've been reading, too!How to Save a Life

I saw "How to Save a Friend from the Brink" on CNN Health the other day and it reminded me of a friend who had expressed suicidal thoughts during a long fight with cancer. In this article, people who have been there provide insight on what friends and family should say and do during critical moments.

Lena Huang

Fitness & Nutrition EditorProstate Cancer Screening

There's been a lot of prostate cancer in the news lately with the American Cancer Society's updated guidelines on prostate cancer screening and the recent Genitourinary Cancers Symposium. The New York Times published "The Great Prostate Mistake," a column on prostate cancer screening written by Richard J. Ablin, who discovered PSA (prostate-specific antigen). Yesterday, readers responded in "Should I Get the Prostate Cancer Test?" Both are a good read and are perfect examples of why this screening controversy is just that--which is why "Talk to your doctor" is more important now than ever.

Elizabeth Whittington

Managing Editor, curetoday.comYour Job

I found this Cancer and Careers workbook, Living and Working with Cancer, while I was doing research for an upcoming article. It's an 81-page workbook that helps walk cancer patients through coordinating their jobs/careers after and during a cancer diagnosis. It summarizes the various laws and options that benefit patients, including ADA, FMLA, and disability, and also offers advice on how to deal with coworkers, manage work responsibilities, returning to work after taking time off, keeping a work diary, etc. The last 50 pages or so are worksheets patients and survivors can use create their own "cancer workbook."

Bunmi Ishola

Editorial assistant

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Dr. Breelyn Wilky urged newly diagnosed GIST patients to seek support from peers and advocacy groups, and to consult experts, even if care stays local.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Related Content